OTCM
LSDIF
Market cap0kUSD
Jul 08, Last price
0.00USD
1D
0.00%
1Q
-50.00%
IPO
-100.00%
Name
Lucy Scientific Discovery Inc
Chart & Performance
P/E
—
P/S
0.03
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
7k
Net income
-9m
L+45.48%
CFO
-4m
L+76.41%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Lucy Scientific Discovery Inc. focuses on the entire lifecycle of psychedelic products, from their initial research and development to their production and subsequent market release. The company's offerings include fundamental biological raw materials, unprocessed extracts, a variety of psychotropic compounds, and critical active pharmaceutical ingredients (APIs). Established in 2017, this firm, formerly known as Hollyweed North Cannabis, Inc., is headquartered in Victoria, Canada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY |
|---|---|---|---|---|
| 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | |
| Income | ||||
Revenues | ||||
Cost of revenue | ||||
Unusual Expense (Income) | ||||
NOPBT | ||||
NOPBT Margin | ||||
Operating Taxes | ||||
Tax Rate | ||||
NOPAT | ||||
Net income | ||||
Dividends | ||||
Dividend yield | ||||
Proceeds from repurchase of equity | ||||
BB yield | ||||
| Debt | ||||
Debt current | ||||
Long-term debt | ||||
Deferred revenue | ||||
Other long-term liabilities | ||||
Net debt | ||||
| Cash flow | ||||
Cash from operating activities | ||||
CAPEX | ||||
Cash from investing activities | ||||
Cash from financing activities | ||||
FCF | ||||
| Balance | ||||
Cash | ||||
Long term investments | ||||
Excess cash | ||||
Stockholders' equity | ||||
Invested Capital | ||||
ROIC | ||||
ROCE | ||||
| EV | ||||
Common stock shares outstanding | ||||
Price | ||||
Market cap | ||||
EV | ||||
EBITDA | ||||
EV/EBITDA | ||||
Interest | ||||
Interest/NOPBT | ||||